Repare Therapeutics Inc Cash Flow Reinvestment Rate

Latest as of September 2025: 0.96x

Repare Therapeutics Inc cash flow reinvestment rate. Repare Therapeutics Inc (RPTX) has a Cash Flow Reinvestment Rate of 0.96x as of September 2025, reinvesting $2.54 Million (capex $0.00 plus investments $2.54 Million) from operating cash flow of $2.65 Million. Explore Repare Therapeutics Inc (RPTX) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.96x
(Capex + Investments) / Operating CF

Total Reinvested

$2.54 Million
Capex + Investments

Operating Cash Flow

$2.65 Million
USD

Capital Expenditures

$0.00
USD

Cash Flow Reinvestment Rate of Repare Therapeutics Inc (2022–2022)

Cash flow reinvestment rate of Repare Therapeutics Inc from 2022 to 2022. Historical reinvestment intensity for Repare Therapeutics Inc across 1 annual periods. Explore Repare Therapeutics Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Repare Therapeutics Inc Cash Flow Reinvestment Rate by Year (2022–2022)

Repare Therapeutics Inc cash flow reinvestment rate by year from 2022 to 2022. Year-by-year capital reinvestment analysis for Repare Therapeutics Inc. For the full cash flow conversion analysis, see Repare Therapeutics Inc cash flow conversion.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2022 547.76x $176.38 Million $322.00K $602.00K —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow